Bundamedik Tbk PT (BMHS) — Capital Reinvestment Ratio
Bundamedik Tbk PT (BMHS) has a Capital Reinvestment Ratio of 0.58x as of December 2025, meaning it reinvests 1% of its operating cash flow (Rp199.64 Billion) in capital expenditures (Rp116.26 Billion). See Bundamedik Tbk PT balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bundamedik Tbk PT Capital Reinvestment Ratio (2018–2025)
This chart tracks Bundamedik Tbk PT's Capital Reinvestment Ratio across 8 annual periods. Check BMHS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Bundamedik Tbk PT (2018–2025)
Year-by-year Capital Reinvestment Ratio for Bundamedik Tbk PT from 2018 to 2025. For live market cap and broader valuation context, see BMHS market cap overview.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.87x | Rp250.62 Billion | Rp218.91 Billion | ▼ -87.4% |
| 2024 | 6.95x | Rp33.98 Billion | Rp236.03 Billion | ▲ +70.7% |
| 2023 | 4.07x | Rp51.44 Billion | Rp209.35 Billion | ▲ +220.3% |
| 2022 | 1.27x | Rp237.47 Billion | Rp301.73 Billion | ▲ +94.7% |
| 2021 | 0.65x | Rp349.44 Billion | Rp228.08 Billion | ▲ +150.5% |
| 2020 | 0.26x | Rp190.36 Billion | Rp49.61 Billion | ▼ -67.8% |
| 2019 | 0.81x | Rp89.72 Billion | Rp72.50 Billion | ▼ -77.4% |
| 2018 | 3.57x | Rp43.79 Billion | Rp156.54 Billion | — |